112 related articles for article (PubMed ID: 18006760)
1. Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
Aoki H; Yokoyama T; Fujiwara K; Tari AM; Sawaya R; Suki D; Hess KR; Aldape KD; Kondo S; Kumar R; Kondo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6603-9. PubMed ID: 18006760
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis.
Kim SH; Lee HW; Kim YH; Koo YH; Chae HD; Kim CH; Lee PR; Kang BM
Hum Reprod; 2009 May; 24(5):1133-41. PubMed ID: 19168872
[TBL] [Abstract][Full Text] [Related]
3. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
5. Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells.
Santra M; Zhang X; Santra S; Jiang F; Chopp M
Cancer Res; 2006 Dec; 66(24):11726-35. PubMed ID: 17178868
[TBL] [Abstract][Full Text] [Related]
6. P21-activated protein kinase 1 is overexpressed in gastric cancer and induces cancer metastasis.
Li LH; Luo Q; Zheng MH; Pan C; Wu GY; Lu YZ; Feng B; Chen XH; Liu BY
Oncol Rep; 2012 May; 27(5):1435-42. PubMed ID: 22293972
[TBL] [Abstract][Full Text] [Related]
7. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme.
Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q
J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323
[TBL] [Abstract][Full Text] [Related]
8. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.
Fowler A; Thomson D; Giles K; Maleki S; Mreich E; Wheeler H; Leedman P; Biggs M; Cook R; Little N; Robinson B; McDonald K
Eur J Cancer; 2011 Apr; 47(6):953-63. PubMed ID: 21196113
[TBL] [Abstract][Full Text] [Related]
9. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
[TBL] [Abstract][Full Text] [Related]
10. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue.
Lama G; Mangiola A; Anile C; Sabatino G; De Bonis P; Lauriola L; Giannitelli C; La Torre G; Jhanwar-Uniyal M; Sica G; Maira G
Int J Oncol; 2007 Jun; 30(6):1333-42. PubMed ID: 17487353
[TBL] [Abstract][Full Text] [Related]
11. Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells.
Guo H; Gu F; Li W; Zhang B; Niu R; Fu L; Zhang N; Ma Y
J Neurochem; 2009 Apr; 109(1):203-13. PubMed ID: 19187446
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
[TBL] [Abstract][Full Text] [Related]
13. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time.
Nafe R; Franz K; Schlote W; Schneider B
Oncol Rep; 2006 Sep; 16(3):555-62. PubMed ID: 16865255
[TBL] [Abstract][Full Text] [Related]
14. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas.
Nafe R; Franz K; Schlote W; Schneider B
Clin Cancer Res; 2005 Mar; 11(6):2141-8. PubMed ID: 15788659
[TBL] [Abstract][Full Text] [Related]
15. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications.
Mangiola A; Lama G; Giannitelli C; De Bonis P; Anile C; Lauriola L; La Torre G; Sabatino G; Maira G; Jhanwar-Uniyal M; Sica G
Clin Cancer Res; 2007 Dec; 13(23):6970-7. PubMed ID: 18056172
[TBL] [Abstract][Full Text] [Related]
16. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.
Chang CY; Li MC; Liao SL; Huang YL; Shen CC; Pan HC
J Clin Neurosci; 2005 Nov; 12(8):930-3. PubMed ID: 16326273
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
[TBL] [Abstract][Full Text] [Related]
19. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
20. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]